This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: The purpose of this article is to summarize the evidence regarding the role of FDG PET/CT in treatment response assessment and surveillance of lung cancer and to provide suggested best practices. CONCLUSION: FDG PET/CT is a valuable imaging tool for assessing treatment response for patients with lung cancer, though evidence for its comparative effectiveness with chest CT is still evolving. FDG PET/CT is most useful when there is clinical suspicion or other evidence for disease recurrence or metastases. The sequencing, cost analysis, and comparative effectiveness of FDG PET/CT and conventional imaging modalities in the follow-up setting need to be investigated.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sheikhbahaei et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: